These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 25226550)

  • 1. Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.
    Mitsis EM; Riggio S; Kostakoglu L; Dickstein DL; Machac J; Delman B; Goldstein M; Jennings D; D'Antonio E; Martin J; Naidich TP; Aloysi A; Fernandez C; Seibyl J; DeKosky ST; Elder GA; Marek K; Gordon W; Hof PR; Sano M; Gandy S
    Transl Psychiatry; 2014 Sep; 4(9):e441. PubMed ID: 25226550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Positron-Emission Tomography in Former National Football League Players.
    Stern RA; Adler CH; Chen K; Navitsky M; Luo J; Dodick DW; Alosco ML; Tripodis Y; Goradia DD; Martin B; Mastroeni D; Fritts NG; Jarnagin J; Devous MD; Mintun MA; Pontecorvo MJ; Shenton ME; Reiman EM
    N Engl J Med; 2019 May; 380(18):1716-1725. PubMed ID: 30969506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral [
    Dickstein DL; Pullman MY; Fernandez C; Short JA; Kostakoglu L; Knesaurek K; Soleimani L; Jordan BD; Gordon WA; Dams-O'Connor K; Delman BN; Wong E; Tang CY; DeKosky ST; Stone JR; Cantu RC; Sano M; Hof PR; Gandy S
    Transl Psychiatry; 2016 Sep; 6(9):e900. PubMed ID: 27676441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid PET across the cognitive spectrum in former professional and college American football players: findings from the DIAGNOSE CTE Research Project.
    Stern RA; Trujillo-Rodriguez D; Tripodis Y; Pulukuri SV; Alosco ML; Adler CH; Balcer LJ; Bernick C; Baucom Z; Marek KL; McClean MD; Johnson KA; McKee AC; Stein TD; Mez J; Palmisano JN; Cummings JL; Shenton ME; Reiman EM;
    Alzheimers Res Ther; 2023 Oct; 15(1):166. PubMed ID: 37798671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.
    Barrio JR; Small GW; Wong KP; Huang SC; Liu J; Merrill DA; Giza CC; Fitzsimmons RP; Omalu B; Bailes J; Kepe V
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2039-47. PubMed ID: 25848027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy.
    Gandy S; DeKosky ST
    F1000Res; 2014; 3():229. PubMed ID: 25469232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report:
    Krishnadas N; Doré V; Lamb F; Groot C; McCrory P; Guzman R; Mulligan R; Huang K; O'Donnell M; Ponsford J; Hopwood M; Villemagne VL; Rowe CC
    Front Neurol; 2020; 11():598980. PubMed ID: 33414760
    [No Abstract]   [Full Text] [Related]  

  • 8. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy.
    Lesman-Segev OH; La Joie R; Stephens ML; Sonni I; Tsai R; Bourakova V; Visani AV; Edwards L; O'Neil JP; Baker SL; Gardner RC; Janabi M; Chaudhary K; Perry DC; Kramer JH; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2019; 24():102025. PubMed ID: 31670152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
    Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
    Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).
    VanItallie TB
    Metabolism; 2019 Nov; 100S():153943. PubMed ID: 31610856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmortem Autopsy-Confirmation of Antemortem [F-18]FDDNP-PET Scans in a Football Player With Chronic Traumatic Encephalopathy.
    Omalu B; Small GW; Bailes J; Ercoli LM; Merrill DA; Wong KP; Huang SC; Satyamurthy N; Hammers JL; Lee J; Fitzsimmons RP; Barrio JR
    Neurosurgery; 2018 Feb; 82(2):237-246. PubMed ID: 29136240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases.
    Gatson JW; Stebbins C; Mathews D; Harris TS; Madden C; Batjer H; Diaz-Arrastia R; Minei JP
    J Neurosurg; 2016 Jun; 124(6):1646-53. PubMed ID: 26613169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.
    Martersteck A; Ayala I; Ohm DT; Spencer C; Coventry C; Weintraub S; Bigio EH; Mesulam M-; Geula C; Rogalski E
    Acta Neuropathol Commun; 2022 Aug; 10(1):111. PubMed ID: 35945628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
    Zannas AS; Doraiswamy PM; Shpanskaya KS; Murphy KR; Petrella JR; Burke JR; Wong TZ
    Neurocase; 2014 Aug; 20(4):466-73. PubMed ID: 23672654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition.
    Mitsis EM; Bender HA; Kostakoglu L; Machac J; Martin J; Woehr JL; Sewell MC; Aloysi A; Goldstein MA; Li C; Sano M; Gandy S
    Mol Neurodegener; 2014 Feb; 9():10. PubMed ID: 24484858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
    Clark CM; Pontecorvo MJ; Beach TG; Bedell BJ; Coleman RE; Doraiswamy PM; Fleisher AS; Reiman EM; Sabbagh MN; Sadowsky CH; Schneider JA; Arora A; Carpenter AP; Flitter ML; Joshi AD; Krautkramer MJ; Lu M; Mintun MA; Skovronsky DM;
    Lancet Neurol; 2012 Aug; 11(8):669-78. PubMed ID: 22749065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.
    Carswell CJ; Win Z; Muckle K; Kennedy A; Waldman A; Dawe G; Barwick TD; Khan S; Malhotra PA; Perry RJ
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):294-299. PubMed ID: 29018162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.